Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 206

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer

Yeh, Chi-Tai, Wu, Alexander T. H., Chang, Peter M.-H., Chen, Kuan-Yu, Yang, Chia-Ning, Yang, Shuenn-Chen, Ho, Chao-Chi, Chen, Chun-Chi, Kuo, Yu-Lun, Lee, Pei-Ying, Liu, Yu-Wen, Yen, Chueh-Chuan, Hsiao, Michael, Lu, Pei-Jung, Lai, Jin-Mei, Wang, Liang-Shun, Wu, Chih-Hsiung, Chiou, Jeng-Fong, Yang, Pan-Chyr, Huang, Chi-Ying F.·2012·American Journal of Respiratory and Critical Care Medicine

Abstract

RATIONALE: Cancer stem cell (CSC) theory has drawn much attention, with evidence supporting the contribution of stem cells to tumor initiation, relapse, and therapy resistance. OBJECTIVES: To screen drugs that target CSCs to improve the current treatment outcome and overcome drug resistance in patients with lung cancer. METHODS: We used publicly available embryonic stem cell and CSC-associated gene signatures to query the Connectivity Map for potential drugs that can, at least in part, reverse the gene expression profile of CSCs. High scores were noted for several phenothiazine-like antipsychotic drugs, including trifluoperazine. We then treated lung CSCs with different EGFR mutation status with trifluoperazine to examine its anti-CSC properties. Lung CSCs resistant to epidermal growth factor receptor-tyrosine kinase inhibitor or cisplatin were treated with trifluoperazine plus gefitinib or trifluoperazine plus cisplatin. Animal models were used for in vivo validation of the anti-CSC effect and synergistic effect of trifluoperazine with gefitinib. MEASUREMENTS AND MAIN RESULTS: We demonstrated that trifluoperazine inhibited CSC tumor spheroid formation and down-regulated the expression of CSC markers (CD44/CD133). Trifluoperazine inhibited Wnt/β-catenin signaling in gefitinib-resistant lung cancer spheroids. The combination of trifluoperazine with either gefitinib or cisplatin overcame drug resistance in lung CSCs. Trifluoperazine inhibited the tumor growth and enhanced the inhibitory activity of gefitinib in lung cancer metastatic and orthotopic CSC animal models. CONCLUSIONS: Using in silico drug screening by Connectivity Map followed by empirical validations, we repurposed an existing phenothiazine-like antipsychotic drug, trifluoperazine, as a potential anti-CSC agent that could overcome epidermal growth factor receptor-tyrosine kinase inhibitor and chemotherapy resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201207-1180oc

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 206

Metadata

Authors
Yeh, C.-T., Wu, A. T. H., Chang, P. M.-H., Chen, K.-Y., Yang, C.-N., Yang, S.-C., Ho, C.-C., Chen, C.-C., Kuo, Y.-L., Lee, P.-Y., Liu, Y.-W., Yen, C.-C., Hsiao, M., Lu, P.-J., Lai, J.-M., Wang, L.-S., Wu, C.-H., Chiou, J.-F., Yang, P.-C., & Huang, C.-Y. F.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2012-12-01
Volume
186
Issue
11
Pages
1180-1188
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2138050607
Cited by
206
References
6
FWCI
5.25
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer. https://app.cochat.ai/papers/10.1164/rccm.201207-1180oc
The paper
Yeh, C.-T., Wu, A. T. H., Chang, P. M.-H., Chen, K.-Y., Yang, C.-N., Yang, S.-C., Ho, C.-C., Chen, C.-C., Kuo, Y.-L., Lee, P.-Y., Liu, Y.-W., Yen, C.-C., Hsiao, M., Lu, P.-J., Lai, J.-M., Wang, L.-S., Wu, C.-H., Chiou, J.-F., Yang, P.-C., & Huang, C.-Y. F. (2012). Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201207-1180oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.